Reducing chronic infections from the bacterium Helicobacter pylori would be a key strategy for preventing stomach cancer, according to research published today. To generate conclusive evidence, Oxford researchers used high-quality data from the prospective China Kadoorie Biobank (CKB) study.
A new study sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.
Oxford researchers will lead a \u00a32m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.
Rob Stepney participated in a radiotherapy clinical trial in Oxford in 2021. He talks about his experience on the trial and accessing a state-of-the-art machine that uses real-time imaging to improve tumour targeting.
An Oxford study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic, but cancer diagnosis following admission to intensive care was higher.
Research by Oxford University Hospital academics have found the images and data available for training AI to spot skin cancer are insufficient and include very few images of darker skin.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms, in the largest study of its kind.
Researchers from the University of Oxford have identified which vaccinated people are at greatest risk from severe Covid-19 leading to hospitalisation or death, from 14 days after the second dose of vaccination, when substantial immunity should be expected.
A paper led by Dr Zhiyuan Hu from Professor Ahmed Ahmed\u2019s lab has won the Columbia Hospital for Women Research Foundation\u2019s 2020-2021 prize for impact.
For the fourth year running the University of Oxford has been ranked first in the world for Computer Science in the 2022 World University Rankings. Many Oxford Cancer members are working in computer science to develop AI algorithms to detect cancer earlier, and implement machine learning into new technologies.
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
A collaboration between mathematicians, pathologists and clinicians has shown how techniques from computational algebraic topology can be used to understand the spatial distributions of immune cell subtypes within tumours.
The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year. Six new Oxford fellowships were announced, including two significant cancer projects.
The 'What Matters Most\u2019 initiative was designed as a way of bringing people with Myelodyspastic Syndrome together to talk about their shared experience, and agree a list of priorities for research and service / resource development.
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
A study from the Fairfax lab provides new insight into the factors that determine patient response to Immune Checkpoint Blockers, a common immunotherapy treatment for melanoma.
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
![\"Graphic](\"https://www.cancer.ox.ac.uk/news/new-study-confirms-an-infectious-bacterium-is-a-major-cause-of-stomach-cancer-in-china/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n